| AZGP1 |
AZGP1, tcag7.638: Alpha-2-glycoprotein 1, zinc-binding |
HLA-DMB |
HLA-DMB, DMB, RING7: HLA class II histocompatibility antigen, DM beta chain prec |
1.132 |
Evidence |
|
| PTAFR |
PTAFR, PAFR: Platelet-activating factor receptor |
GNAQ |
GNAQ, GAQ: Guanine nucleotide-binding protein G(q) subunit alpha |
1.132 |
Evidence |
|
| PTAFR |
PTAFR, PAFR: Platelet-activating factor receptor |
GNAI2 |
Galphai2 protein |
1.132 |
Evidence |
|
| PTAFR |
PTAFR, PAFR: Platelet-activating factor receptor |
GNA13 |
GNA13: Guanine nucleotide-binding protein alpha-13 subunit |
1.132 |
Evidence |
|
| PTAFR |
PTAFR, PAFR: Platelet-activating factor receptor |
GNA12 |
GNA12: Guanine nucleotide-binding protein alpha-12 subunit |
1.132 |
Evidence |
|
| PTAFR |
PTAFR, PAFR: Platelet-activating factor receptor |
GNAI1 |
GNAI1: Guanine nucleotide-binding protein G(i), alpha-1 subunit |
1.132 |
Evidence |
|
| PTAFR |
PTAFR, PAFR: Platelet-activating factor receptor |
GNA15 |
GNA15, GNA16: Guanine nucleotide-binding protein alpha-15 subunit |
1.132 |
Evidence |
|
| PTAFR |
PTAFR, PAFR: Platelet-activating factor receptor |
GNA11 |
GNA11, GA11: Guanine nucleotide-binding protein subunit alpha-11 |
1.132 |
Evidence |
|
| PTAFR |
PTAFR, PAFR: Platelet-activating factor receptor |
GNAO1 |
GNAO1: Guanine nucleotide-binding protein G(o) subunit alpha 2 |
1.132 |
Evidence |
|
| IL4R |
IL4R, 582J2.1, IL4RA: Interleukin-4 receptor alpha chain precursor |
IL2 |
IL2: Interleukin 2 |
1.132 |
Evidence |
|
| IL4R |
IL4R, 582J2.1, IL4RA: Interleukin-4 receptor alpha chain precursor |
THPO |
THPO, MGDF: Thrombopoietin precursor |
1.132 |
Evidence |
|
| PTPRG |
PTPRG, PTPG: Receptor-type tyrosine-protein phosphatase gamma precursor |
SLC4A3 |
SLC4A3, AE3: Anion exchange protein 3 |
1.132 |
Evidence |
|
| TBXA2R |
TBXA2R: Thromboxane A2 receptor |
GNA13 |
GNA13: Guanine nucleotide-binding protein alpha-13 subunit |
1.132 |
Evidence |
|
| TBXA2R |
TBXA2R: Thromboxane A2 receptor |
GNA15 |
GNA15, GNA16: Guanine nucleotide-binding protein alpha-15 subunit |
1.132 |
Evidence |
|
| C5AR1 |
C5AR1, C5AR, C5R1: C5a anaphylatoxin chemotactic receptor |
GNAS |
GNAS, GNAS1, GSP: Guanine nucleotide-binding protein G(s) subunit alpha isoforms |
1.132 |
Evidence |
|
| DRD1 |
DRD1: D(1A) dopamine receptor |
GNAS |
GNAS, GNAS1, GSP: Guanine nucleotide-binding protein G(s) subunit alpha isoforms |
1.132 |
Evidence |
|
| KITLG |
KITLG, MGF, SCF: Kit ligand precursor |
IL4R |
IL4R, 582J2.1, IL4RA: Interleukin-4 receptor alpha chain precursor |
1.132 |
Evidence |
|
| RASA1 |
RASA1, RASA: Ras GTPase-activating protein 1 |
TESK1 |
TESK1: Dual specificity testis-specific protein kinase 1 |
1.132 |
Evidence |
|
| RASA1 |
RASA1, RASA: Ras GTPase-activating protein 1 |
PTK6 |
PTK6, BRK: Tyrosine-protein kinase 6 |
1.132 |
Evidence |
|
| RASA1 |
RASA1, RASA: Ras GTPase-activating protein 1 |
BMX |
IPI00514142 |
1.132 |
Evidence |
|
| RASA1 |
RASA1, RASA: Ras GTPase-activating protein 1 |
MATK |
MATK, CTK, HYL: Megakaryocyte-associated tyrosine-protein kinase |
1.132 |
Evidence |
|
| TNFRSF1B |
TNFRSF1B, TNFBR, TNFR2: Tumor necrosis factor receptor superfamily member 1B pre |
TNFSF13B |
TNFSF13B, BAFF, UNQ401/PRO738, BLYS, TALL1, TNFSF20, ZTNF4: Tumor necrosis facto |
1.132 |
Evidence |
|
| TNFRSF1B |
TNFRSF1B, TNFBR, TNFR2: Tumor necrosis factor receptor superfamily member 1B pre |
EDA |
IPI00023765 |
1.132 |
Evidence |
|
| PLCG1 |
PLCG1, PLC1: 1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase gamma-1 |
PTK2B |
PTK2B, FAK2, PYK2, RAFTK: Protein tyrosine kinase 2 beta |
1.132 |
Evidence |
|
| PLCG1 |
PLCG1, PLC1: 1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase gamma-1 |
ITK |
ITK, EMT, LYK: Tyrosine-protein kinase ITK/TSK |
1.132 |
Evidence |
O
|